Yet, under federal law, it is labeled "rare" because that definition is based on prevalence —a static snapshot of how many ...

Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's disease, can affect the way you move, breathe, eat, and behave.

Study shows how ALS-linked mutations disrupt the protein TDP-43 at the atomic level, preventing it from executing its ...

Neuvivo and the FDA have agreed on a regulatory pathway for NP001 (sodium chlorite) to treat ALS, with Phase 3 testing ...

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by the progressive degeneration of motor neurons, leading to muscle weakness and eventually death.

Elon Musk's brain implant company Neuralink said on Thursday it will launch a clinical study in Great Britain to test how its ...

Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease, with an incidence of 1 or 2 cases per 100,000 persons and a lifetime risk of 1 case per 800 persons.